CAS 2095514-75-1

1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-5-methyl-3-[2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-, (3S)-

Description:

1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-5-methyl-3-[2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-, (3S)- is a complex organic compound characterized by its unique bicyclic structure that incorporates both benzoxazepine and pyrazolopyridine moieties. This compound features a fused ring system, which contributes to its potential biological activity. The presence of various functional groups, including a ketone and multiple methyl groups, suggests that it may exhibit diverse chemical reactivity and interactions. The stereochemistry indicated by the (3S) designation implies specific spatial arrangements of atoms, which can influence the compound's pharmacological properties. Such compounds are often investigated for their potential therapeutic applications, particularly in the fields of medicinal chemistry and drug development. Additionally, the compound's molecular weight, solubility, and stability under various conditions would be essential for understanding its behavior in biological systems and its suitability for further research or application.

Formula: C₂₃H₂₂N₄O₃

Synonyms:

• 1,5-Benzoxazepin-4(5H)-one, 2,3-dihydro-5-methyl-3-[2,4,5,7-tetrahydro-7-oxo-2-(phenylmethyl)-6H-pyrazolo[3,4-c]pyridin-6-yl]-, (3S)-
• TP-030-1

TP-030-1

CAS: 2095514-75-1

TP-030-1, RIPK1 inhibitor: K(i) hRIPK1 at 3.9nM, IC50 mRIPK1 at 4.2μM; targets inflammation, neurodegeneration research.

Formula: C₂₃H₂₂N₄O₃

Color and Shape: Solid

Molecular weight: 402.45

Ref: TM-T73374